SCHEMBL24075865

SCHEMBL24075865

CCC(C)NCCNCCCCNC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.39
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 2/20 0.36
CYP1A2 P05177 1/20 0.36
PAOX Q6QHF9 1/20 0.34
S1PR2 O95136 5/20 0.33
S1PR4 O95977 5/20 0.33
S1PR1 P21453 5/20 0.33
S1PR3 Q99500 5/20 0.33
KDM4E B2RXH2 3/20 0.33
HTT P42858 1/20 0.33
S1PR5 Q9H228 1/20 0.33
MEN1 O00255 1/20 0.32
GLA P06280 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 1/20 0.31
POLB P06746 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
KDM1A O60341 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22814103 0.92 CYP2C19 (0.41) EPHX1ALDH1A1TSHRCYP2C19CYP1A2
SCHEMBL4747076 0.84 KDM4E (0.36) ALDH1A1TSHRCYP2C19KDM4EHTT
SCHEMBL3692235 0.84 KDM4E (0.36) ALDH1A1TSHRCYP2C19KDM4EHTT
SCHEMBL4745035 0.84 KDM4E (0.36) ALDH1A1TSHRCYP2C19KDM4EHTT
SCHEMBL3697961 0.82 ALDH1A1 (0.43) ALDH1A1TSHRCYP2C19CYP1A2S1PR2
SCHEMBL24693886 0.82 EPHX1 (0.40) EPHX1ALDH1A1TSHRKDM4EHTT
SCHEMBL14065623 0.82
SCHEMBL29324153 0.82
SCHEMBL10045264 0.80 CYP2C19 (0.46) ALDH1A1TSHRCYP2C19CYP1A2KDM4E
SCHEMBL23489714 0.78 CA12 (0.50) ALDH1A1TSHRCYP2C19CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345678-B2 Benzopyrazole compound used as RHO kinase inhibitor MEDSHINE DISCOVERY INC. (CN) 2022-05-31 US disclosed
US-20210371393-A1 BENZOPYRAZOLE COMPOUND USED AS RHO KINASE INHIBITOR MEDSHINE DISCOVERY INC. (CN) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345678-B2 Benzopyrazole compound used as RHO kinase inhibitor ROCK1, ROCK2, CIT EPHX1 1248/4885ALDH1A1 2343/4885TSHR 4592/4885
US-20210371393-A1 BENZOPYRAZOLE COMPOUND USED AS RHO KINASE INHIBITOR ROCK1, ROCK2, CIT EPHX1 1248/4885ALDH1A1 2343/4885TSHR 4592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.